Impact Evaluation of Personalized Oral Hygiene Education on Periodontal Patients Stage I/II/III (HygParo)
Evaluation of personalized oral hygiene education on plaque accumulation and gingival inflammation in periodontal patients stage I/II/III.
Evaluation of personalized oral hygiene education on clinical attachment level in periodontal patients stage I/II/III.
Evaluation of personalized oral hygiene education on the psychological determinants described by the Health Action Process Approach (HAPA) and the mediating role of these psychological determinants in oral hygiene habits and clinical parameters in periodontal patients stage I/II/III.
研究概览
地位
研究类型
注册 (预期的)
联系人和位置
学习地点
-
-
-
Strasbourg、法国、67091
- Les Hôpitaux Universitaires de Strasbourg
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
描述
Inclusion criteria:
- ≥ 18 years old
- Subject having signed an informed consent
- Subjects with periodontal disease Stage I/II/III :
- ≥ 15 teeth/implants
- Bleeding index at ≥ 25%
- Plaque index ≥ 20%
- Not requiring antibiotic prophylaxis prior to periodontal treatment.
- Not having received surgical periodontal treatment in the last 12 months.
- Smokers of ≤10 cigarettes/day
Exclusion criteria:
- <15 teeth/implants
- Physical or mental disability that does not allow for the performance of oral hygiene procedures.
- Chronic progressive pathology (diabetes...) / immunodeficiencies (HIV...)/ systemic infections.
- Ongoing drug treatment leading to a significant change in the periodontal condition (anti-epileptics, calcium antagonists, immunosuppressants, hormonal treatments, etc.).
- Ongoing drug treatment that can influence the periodontal condition (anti-inflammatory drugs, antibiotics)
- Patients with severe xerostomia or with Gougerot-Sjögren's syndrome.
- Subjects undergoing treatment for cancer
- Pregnant or breastfeeding women
- Smokers of > 10 cigarettes/day
- Impossibility to give information about the subject (subject in an emergency situation, difficulties in understanding the French language, etc.).
- Subject under safeguard of justice
- Subject under guardianship or curatorship
学习计划
研究是如何设计的?
设计细节
队列和干预
团体/队列 |
干预/治疗 |
---|---|
Control group: Dental model
Patients diagnosed with periodontal disease stage I/II/III
|
- Patients receive a demonstration of plaque control methods (modified Bass dental brushing technique and the use of the electric toothbrush) using a dental model.
|
Computer-assisted teaching format group
Patients diagnosed with periodontal disease stage I/II/III
|
- Patients receive a Powerpoint presentation containing:
|
Plaque-disclosing group
Patients diagnosed with periodontal disease stage I/II/III
|
- Patients place a few drops of a plaque-disclosing solution on the tongue and run the tongue over all the teeth and gums.
With the aid of a hand mirror, patients can observe the stained plaque residue on their teeth
|
Intra-oral Camera group
Patients diagnosed with periodontal disease stage I/II/III
|
- An ACTEON Soprocare® intraoral camera is used during the examination and explanation of oral hygiene strategies.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Evaluation of the plaque index
大体时间:3 months
|
Plaque Index (Loë and Silness, 1963): Six surfaces per tooth (buccal, mesio-buccal, disto-buccal, lingual, mesio-lingual and disto-lingual) are examined in every permanent tooth (except for third molars). Each tooth is assessed with a score between 0 and 3.
|
3 months
|
Evaluation of the gingival index
大体时间:3 months
|
Gingival Index (Loë 1967): Six surfaces per tooth (buccal, mesio-buccal, disto-buccal, lingual, mesio-lingual and disto-lingual) are examined in every permanent tooth (except for third molars).
|
3 months
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Evaluation of probing pocket depth
大体时间:3 months
|
Probing pocket depth (distance from the top of the marginal gingiva to the bottom of the pocket)
|
3 months
|
Evaluation of the gingival attachment level
大体时间:3 months
|
Gingival attachment level (distance separating the cemento-enamel junction from the bottom of the pocket)
|
3 months
|
Psychological determinants of the HAPA (Health Action Process Approach)
大体时间:3 months
|
Change in the psychological determinants of the HAPA questionnaire adapted to oral health, using a 7-point Likert scale from "strongly disagree" (1) to "strongly agree" (7)
|
3 months
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (预期的)
初级完成 (预期的)
研究完成 (预期的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.
Periodontal Disease Stage I/II/III的临床试验
-
Piazza della Vittoria 14 Studio Medico - Ginecologia...完全的
-
Arizona State UniversityCatholic Charities Phoenix; Phoenix International Refugee Committee; Refugee Focus Phoenix; Refugee... 和其他合作者完全的
-
Emory UniversitySynta Pharmaceuticals Corp.终止IVA 期口腔鳞状细胞癌 | IVA 期喉鳞状细胞癌 | IVA 期口咽鳞状细胞癌 | I 期下咽鳞状细胞癌 | I期喉鳞状细胞癌 | I期口咽鳞状细胞癌 | II期下咽鳞状细胞癌 | II期喉鳞状细胞癌 | II期口咽鳞状细胞癌 | III 期下咽鳞状细胞癌 | III期喉鳞状细胞癌 | III 期口咽鳞状细胞癌 | IVA 期下咽鳞状细胞癌 | III 期口腔鳞状细胞癌 | I 期口腔鳞状细胞癌 | II期口腔鳞状细胞癌美国
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)完全的
-
Wake Forest University Health Sciences终止I期口腔腺样囊性癌 | I期口腔粘液表皮样癌 | 下咽部 I 期鳞状细胞癌 | I期喉鳞状细胞癌 | 唇和口腔的 I 期鳞状细胞癌 | I期喉疣状癌 | I期口腔疣状癌 | II期口腔腺样囊性癌 | II期口腔粘液表皮样癌 | 下咽部 II 期鳞状细胞癌 | 喉部 II 期鳞状细胞癌 | 唇和口腔的 II 期鳞状细胞癌 | II期喉疣状癌 | II期口腔疣状癌 | III 期口腔腺样囊性癌 | III 期口腔粘液表皮样癌 | 下咽部 III 期鳞状细胞癌 | 喉部 III 期鳞状细胞癌 | 唇和口腔的 III 期鳞状细胞癌 | III 期喉疣状癌 | III 期口腔疣状癌 | IV 期口腔腺样囊性癌 | IV 期口腔粘液表皮样癌 | 下咽部 IV 期鳞状细胞癌 | IV 期喉鳞状细胞癌 | 唇和口腔的 IV 期鳞状细胞癌 | IV... 及其他条件美国
-
Xinhua Hospital, Shanghai Jiao Tong University...The First Affiliated Hospital of Zhengzhou University; Shanghai Ninth People's Hospital Affiliated... 和其他合作者未知
-
City of Hope Medical CenterNational Cancer Institute (NCI)终止下咽部复发性鳞状细胞癌 | 喉部复发性鳞状细胞癌 | 唇和口腔的复发性鳞状细胞癌 | 复发性口咽鳞状细胞癌 | 复发性喉疣状癌 | 复发性口腔疣状癌 | 复发性口腔腺样囊性癌 | 复发性鼻咽淋巴上皮瘤 | 复发性口咽淋巴上皮瘤 | 复发性口腔粘液表皮样癌 | 复发性鼻咽鳞状细胞癌 | I期口腔腺样囊性癌 | I期鼻咽淋巴上皮瘤 | I期口咽淋巴上皮瘤 | I期口腔粘液表皮样癌 | 下咽部 I 期鳞状细胞癌 | I期喉鳞状细胞癌 | 唇和口腔的 I 期鳞状细胞癌 | I期鼻咽鳞状细胞癌 | I期口咽鳞状细胞癌 | I期喉疣状癌 | I期口腔疣状癌 | II期口腔腺样囊性癌 | II期鼻咽淋巴上皮瘤 | II期口咽淋巴上皮瘤 | II期口腔粘液表皮样癌 | 下咽部 II 期鳞状细胞癌 | 喉部 II 期鳞状细胞癌 | 唇和口腔的 II 期鳞状细胞癌 | II期鼻咽鳞状细... 及其他条件美国
-
Massachusetts General Hospital招聘中
-
Indiana University完全的
-
National Cancer Institute (NCI)完全的复发性下咽鳞状细胞癌 | 复发性喉鳞状细胞癌 | 复发性口咽鳞状细胞癌 | 复发性唇和口腔鳞状细胞癌 | 复发性喉疣状癌 | 复发性口腔疣状癌 | 舌癌 | IV 期下咽鳞状细胞癌 | IVA 期喉鳞状细胞癌 | IVA 期喉疣状癌 | IVA 期唇和口腔鳞状细胞癌 | IVA 期口腔疣状癌 | IVA 期口咽鳞状细胞癌 | I 期下咽鳞状细胞癌 | I期喉鳞状细胞癌 | I 期唇和口腔鳞状细胞癌 | I期口咽鳞状细胞癌 | II期下咽鳞状细胞癌 | II期喉鳞状细胞癌 | II 期唇和口腔鳞状细胞癌 | II期口咽鳞状细胞癌 | III 期下咽鳞状细胞癌 | III期喉鳞状细胞癌 | III 期唇部和口腔鳞状细胞癌 | III 期口咽鳞状细胞癌 | I期喉疣状癌 | I 期口腔疣状癌 | II期喉疣状癌 | II 期口腔疣状癌 | III期喉疣状癌 | III 期口腔疣状癌美国
Control group: Dental Model的临床试验
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)完全的肥胖 | 心血管危险因素 | 糖尿病风险